MolecularMD Raises $3M
Luke Timmerman2/2/09
MolecularMD, a Portland, OR-based maker of molecular diagnostic tests for cancer, has raised $3 million in a new round of financing, according to data from VentureDeal. The company was founded in 2006 on technology from Brian Druker and Michael Heinrich at Oregon Health & Science University.
Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.
MedCity morning read Tuesday, Feb. 3 : MedCity News
2/3/09 7:15 am
[...] Portland’s MolecularMD Raises $3M (Xconomy) [...]